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ABSTRACT 
Dibutyltin dichloride (DBTC) is an organotin compound used as model for acute and chronic pancreatitis. Oxi-
dative stress is one of the mechanisms of propagation of acinar cell injury in acute pancreatitis. Selenium is an 
essential cofactor in the antioxidant glutathione peroxidase pathway. Selenium levels are described to be subnor-
mal in patients with acute and chronic pancreatitis. The aim of our studies was to determine the prophylactic effect 
of Na-selenite [5 mg kg-1 body weight (b.w.) per os (p.o.) 7 days] on the pathogenesis and course of DBTC- 
induced pancreatitis. Male inbred rats (LEW-1W Charles River) of 150 g body weight were used in this study. 
Experimental pancreatitis was induced by intravenous administration of 6 mg kg-1 b.w. DBTC in rats. Na-selenite 
was administered as daily oral dose of 5 mg kg-1 b.w. 7 days before induction of DBTC-pancreatitis. Malondial-
dehyde (MDA) was measured for monitoring levels of oxidative stress. Elimination of DBTC was reflected as 
tin concentration in bile and urine. Organ changes were indicated by serum parameters as well as histology. A 
prophylactic Na-selenite application significantly diminished MDA- and bilirubin concentration in serum, activi-
ties of lipase and transaminases as well as organ injuries compared to DBTC- treated rats in the absence of Na-
selenite. The prophylactic oral treatment with Na-selenite in the scope of DBTC-induced pancreatitis points to a 
reduced oxidative stress characterized by diminished MDA serum levels and a milder course of pancreatitis 
suggesting prophylactic substitution with Na-selenite to probably elicit beneficial effect on the clinical 
outcome in patients with endoscopic retrograde cholangiopancreatography (ERCP). 
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INTRODUCTION 
Dibutyltin dichloride (DBTC) is an organ-
otin compound serving as model system for 
analyses of toxicological investigations due 
to various pathological effects on the organ-
ism. In recent years the industrial use of or-
ganotin and its metabolites as stabilizers in 
polyvinylchloride manufacturing, as bio-
cides in agriculture and in antifouling 
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paints has become strongly restricted by 
laws of the European Union (Kimmel et al., 
1977; Merkord, 1994; Gies et al., 2000). 
Several studies focussed on the acute and 
chronic toxic effects of DBTC at doses of 6 
mg kg-1 or 8 mg kg-1 b.w. i.v. Depending on 
time and dose an acute interstitial pancrea-
titis, cholestasis with bile duct and liver le-
sions, depression of the thymus-dependent 
immune system accompanied with thymus 
atrophy were observed in rats (Barnes and 
Magee, 1958; Hennighausen et al., 1980; 
Merkord et al., 1982; Merkord and Hen-
nighausen, 1989; Merkord et al., 1991, 
1995). The mechanisms of DBTC-induced 
pancreatitis were discussed in a former pub-
lication from our group (Merkord et al., 
1997). Biochemical effects of organotin 
compounds like DBTC are interactions at 
dithiol groups, inhibition of mitochondrial 
oxidative phosphorylation and glutathion-S-
transferase activity, as well as activation of 
caspase activity and induction of apoptosis at 
low concentrations (Pennings et al., 1983; 
Gennari et al., 2002). The major parameter 
conferring DBTC-induced pancreatitis is a 
high concentration of organotin in bile after 
administration of DBTC. 4 hours after ap-
plication, elevated levels of organotin were 
measured in different compartments, espe-
cially in bile, liver and pancreas (Merkord et 
al., 1997, 2000). The excretion rate of DBTC 
in urine is low, but appears higher in combi-
nation with chelating agents after 1 to 4 days 
(Merkord et al., 2001). 
Selenium is an essential trace element, 
which can be found in different concentra-
tions in soil and food, especially in yolk of 
an egg, in fish, meat and innards (Kimmel 
et al., 1977). Its deficiency is associated with 
skeletal diseases and cardiac myopathy and 
may increase the risk for cardiovascular dis-
eases and for cancer (Salonen et al., 1985; 
Neve et al., 1985; Albrecht et al., 1994). 
Selenium is a modulator of prostaglan-
din-depended reactions and has antidotal 
effects against nuclear radiation (Schrauzer, 
1990, 1998). Furthermore selenium, as an es-
sential component of glutathione peroxidase, 
plays a critical role in protecting the organism 
against cell injury caused by radical oxygen 
species (Neve et al., 1985; Saint-Georges et 
al., 1989; Zimmermann et al., 2000). Further-
more selenium has been postulated to exert 
anticarcinogenic and antimutagenic properties 
(Schrauzer, 1990, 1998). 
Oxidative stress is one of the mecha-
nisms of propagation of acinar cell injury 
in acute pancreatitis (Birk et al., 1995; 
Schoenberg et al., 1992; Schulz et al., 1999). 
Decreases of serum selenium levels as well 
as activity of glutathione peroxidase were 
found to be associated with acute and chronic 
pancreatitis (Kuklinski et al., 1991, 1995; 
Wollschläger et al., 1999; Gärtner et al., 
1997; McCloy, 1998; Scolapio et al., 2004; 
Zelck and Karnstedt, 1993) 
In experiments using DBTC-induced pan-
creatitis in rats, low therapeutical doses of se-
lenium failed to increase the reduced glutathi-
one peroxidase activity. On the other hand, 
high doses of selenium led, independent of 
state of health of rats, to an increase of gluta-
thione peroxidase in serum (Frommhold et 
al., 1997). Selenium has not yet been found 
to target other antioxidative enzymes such as 
superoxide dismutase (Wollschläger et al., 
1997; Zelck and Karnstedt, 1993). 
Thus taken together the anti-oxidative 
treatment of acute pancreatitis is still contro-
versially discussed (Birk et al., 1995; Kuklin-
ski et al., 1995; Wollschläger et al., 1999; 
Gärtner et al., 1997; Sevillano et al., 2003a, 
b; Virlos et al., 2003; Stopinski et al., 1994). 
Selenium has been reported as a crucial 
modulator of inflammatory reactions. On the 
one hand it activates the transcription factor 
AP-1, which induces a controlled inflamma-
tion and on the other hand it inhibits NF-κB, 
and prevents a massive inflammation (Zim-
mermann et al., 2000; McCloy, 1998; Force-
ville et al., 1998; Zimmermann et al., 1997). 
Another way of diminishing the toxic reac-
tions of metals and organometals in the or-
ganism could be the formation of complexes 
consisting of selenium and noxious sub-
stances. As such selenium decreases the tox-
icity of mercury in vivo via formation of 
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albumin-mercury-selenite complexes accom-
panied by increasing mercury elimination in 
urine (Schrauzer, 1990, 1998; Wu et al., 
1990; Hennighausen and Lange, 1980; Potter 
and Matrone, 1977). Accordingly, selenium 
complexes with DBTC as cause of the re-
duced toxicity appear feasible. An alternative 
explanation for the reduction of DBTC-in-
duced toxicity may lie in a probable reduc-
tion of DBTC-induced lipid peroxidation by 
selenium. Lipid peroxidations are part of re-
actions that induce oxidative stress which is 
characterized by the concentration of malon-
dialdehyde in serum. 
The purpose of this study was to eval-
uate the effect of prophylactic applications 
of Na- selenite as a possible antioxidant pre-
ventive therapy in acute DBTC-induced pan-
creatitis and the protective effect of Na-sel-
enite in diminution the toxicity of DBTC in 
rats. There is the possibility that the admin-
istration of Na-selenite increases the sele-
nium levels in serum concomitant with 
higher activities of glutathione peroxidase. 
Towards these points the oxidative stress in 
scope of DBTC-induced pancreatitis could 
be lowered by a prophylactic treatment by 
selenium. This fact is interesting on the clini-
cal outcome in patients with ERCP. 
We investigated the influence of a daily 
oral prophylactic application of Na-selenite 
over 7 days on the acute toxic effects of a sin-
gle dose of DBTC of 6 mg kg-1 DBTC i.v. in 
rats. 
The pathohistological changes of bile 
duct, liver, pancreas and thymus were exam-
inated by light microscopy 2, 4, 7, 14 and 28 
days after treatment. 
Moreover, pathobiochemical parameters 
of pancreatitis (amylase and lipase activity), 
oxidative stress (malondialdehyde in serum), 
liver lesions (bilirubin and transaminases) 
and cholestasis (alkaline phosphatase) were 
determinated. 
 
METHODS 
Animals and reagents 
8 weeks old male inbred rats (LEW-1W, 
Charles River) of 150  20 g body weight 
were randomly allocated to one of 3 groups 
(n = 6 / group). The experimental groups 
were as follows:  
 Group 1 (Na-selenite): Na-selenite 5 mg 
kg-1 b.w. p.o. daily in a period of 7 days;  
 Group 2 (DBTC): Single dose of 6 mg 
kg-1 b.w. DBTC i.v.;  
 Group 3 (Na-selenite + DBTC): Na-sel-
enite (5 mg kg-1 b.w. p.o. daily in a pe-
riod of 7 days before DBTC application 
in a single dose of 6 mg kg-1 b.w. DBTC 
i.v.). The experiments cover a period of 
4 weeks after DBTC-administration for 
all three test groups. 
Na-selenite was dissolved in sodium 
chloride for oral administration. For intrave-
nous administration DBTC (Sigma-Aldrich 
Chemie GmbH, Steinheim) was first dis-
solved in 100 % ethanol. Two parts of this 
solution were mixed with three parts glyc-
erol. The animals were sacrificed 2, 4, 7, 14 
and 28 days after the day of DBTC applica-
tion. 
Blood collected from the retroorbital 
plexus of rats was examined before and 7 days 
after Na- selenite administration and 1, 2, 4, 
6 and 24 hours after DBTC administration 
for MDA concentration in serum. 
For measurement of biliary excretion of 
tin, animals (five per group) were anaesthe-
tized with pentobarbital (50 mg kg-1 b.w. i.p.) 
and a midline laparotomy was performed. The 
bile duct at the hilium of the liver was cannu-
lated with PE 10 polyethylene tube for a dis-
tance of 0.5 cm. Afterwards, one group was 
treated with a single dose of 6 mg kg-1 b.w. 
DBTC i.v. and the other group with Na-sel-
enite (5 mg kg-1 b.w. p.o. 1 hour before 
DBTC [6 mg kg-1 b.w. i.v.] application). The 
bile was collected after DBTC and Na-selenite 
+ DBTC administration every 60 min of an 
experimental period of 4 hours. 
 
Analyses of morphology 
Tissue samples of biliopancreatic duct, 
pancreas and liver were fixed in calcium for-
malin and processed for histopathological 
examination. Paraffin sections were stained 
with haematoxylin and eosin. 
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Analytical methods 
Blood samples for the determination of 
malondialdehyde (MDA) were drawn after 1, 
2, 4, 6 and 24 hours, for the determination 
of serum alkaline phosphatase, bilirubin and 
transaminases were drawn after 1, 2, 4, 7, 14 
and 28 days and for amylase and lipase 1, 2, 
4 and 7 days after administration of DBTC. 7 
days before and at the day of DBTC applica-
tion we measured these enzymes in serum 
to identify the best time point to start the 
measurements. 
The amylase and lipase activities in se-
rum of rats were measured using a com-
mercially available test kits from Roche Diag-
nostics GmbH (Mannheim, Germany). 
Bilirubin was determined by the DPD 
(2.5-dichlorphenyl diazonium salt) method 
(37° C). 
Alkaline phosphatase was measured by 
an optimized method of the German Society 
of Clinical Chemistry (37° C) with p-nitro-
phenylphosphat as substrate. All these pa-
rameters were measured on the analyzer Hi-
tachi 717 with test kits from Roche Diag-
nostics. Transaminases were measured with 
test kits from Sigma-Aldrich (Steinheim, Ger-
many). The MDA concentration was meas-
ured by HPLC with a test kit from Chro-
mosystems GmbH (Munich, Germany). 
The serum levels of selenium and the con-
centrations of tin in bile, urine, pancreas, liver 
and thymus were estimated by atomic ab-
sorption spectrometry (AAS) after micro-
wave-induced digestion (Merkord et al., 
2000). For the electrothermal determination 
of tin at 286.5 nm, an AAS GBC 908 AA was 
used as previously described (Merkord et al., 
1997). 
 
Statistical analysis and evaluation 
Means of normally distributed data with 
similar variances were compared by Student’s 
t-test. In the case of significant differences in 
variance, means were compared by Welch’s 
t test. Non-normally distributed data were 
evaluated by Wilcoxon test. p 0.05 was 
considered as significant (Sachs, 1992). 
 
RESULTS 
Morphological modulation of the biliopan-
creatic duct by Selenium and DBTC 
In a first attempt to observe morpholog-
ical changes induced upon treatment with 
DBTC, visible changes of the biliopancre-
atic duct were investigated. As expected for 
the DBTC- treated group, the biliopancreatic 
duct was extremely dilated. Total necrosis of 
the surface epithelium of the duct let to adhe-
sion and obstruction of the duct followed by 
cholestasis (Figure 1b) whereas in the Na-sel-
enite-treated group, the biliopancreatic duct 
was not dilated (Figure 1a). The prophylactic 
administration of Na-selenite diminished the 
DBTC-induced lesions of the biliopancreatic 
duct (Figure 1c). 
 
Inhibition of the DBTC-induced patho-
logical modulation of pancreas and liver 
by selenium 
To further analysize morphological 
changes induced upon DBTC treatment and 
prophylactic Na-selenite administration, sec-
tion from pancreas and liver were stained 
with hematoxilin/eosin to visualize the toxic 
impact of the test substances. 
Two days after DBTC treatment acute inter-
stitial pancreatitis with inflammatory cells, 
dilated acinar lumina and scattered acinar 
cell necrosis had developed. In the liver, ede-
mas of the portal tracts were the only signs 
of damage while in the combined treatment 
group of Na-selenite and DBTC the lesions 
appeared milder than in the DBTC-group 
(data not shown). 
Following the treatment period of 7 
days none of the Na-selenite treated rats 
exhibited morphological abnormalties in the 
pancreas (Figure 2a). However, DBTC treat-
ment caused an acute interstitial pancreatitis 
with infiltrates of eosinophilic granulocytes, 
histiocytes, lymphocytes, macrophages and 
plasma cells (Figure 2b) that was reversed 
when rat were pretreated with Na-selenite 
(Figure 2c). 
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a) 
b)  c)  
Figure 1: Impact of Na-selenite on DBTC-induced 
dilatation of the biliopancreatic duct. a) Biliopan-
creatic duct 7 days after Na-selenite administra-
tion. b) Biliopancreatic duct 7 days after DBTC ad-
ministration. c) Biliopancreatic duct 7 days after 
Na-selenite + DBTC administration. Arrows indi-
cate the biliopancreatic duct in the respective im-
age. 
 
 
 
Similar developments were observed in 
the liver. Accordingly, Na-selenite treated rats 
showed no pathological morphology in liver 
tissue (Figure 3a). DBTC induced an acute 
inflammation of portal tracts and paren-
chyma necrosis in the perivenular zone in 
the liver (Figure 3b). As expected from the 
effects of Na-selenite pretreatment on pan-
creatic pathogenensis induced by DBTC, no 
signs of morphological changes in liver were 
observed (Figure 3c). 
 
 
a) 
 
b) 
 
c) 
Figure 2: Influence of Na-selenite on DBTC-in-
duced acute interstitial pancreatitis. Images depict 
hematoxilin/eosin staining of a normal structure of 
pancreas in Na-selenite-treated rats (a, magnifi-
cation x 80) whereas DBTC-induced acute inter-
stitial pancreatitis (b, magnification x 40). In rats 
treated with combination of DBTC and Na-selenite 
a mild interstitial pancreatitis can be noticed (c, 
magnification x 120). Pictures were taken 7 days 
after administration of the indicated test sub-
stances, respectively. Scale bars indicate 100 µm, 
respectively. 
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a) 
b) 
c) 
Figure 3: Influence of Na-selenite on DBTC-in-
duced liver malfunction. Images depict hematox-
ilin/eosin stainings of a normal structure of the 
liver in Na-selenite-treated rats (a, magnification x 
80) whereas DBTC caused inflammation, isolate 
necrosis and intrahepatic bile duct hyperplasia (b, 
magnification x 40). In rats treated with combina-
tion of DBTC and Na-selenite the DBTC- induced 
inflammation, necroses and intrahepatic bile duct 
hyperplasia were reduced (c, magnification 40). 
Pictures were taken 7 days after administration of 
the indicated test substances, respectively. Scale 
bars indicate 100 µm, respectively. 
 
After 28 days one third of the DBTC-
treated animals developed periductal and in-
terstitial fibrosis in the pancreas and obstruc-
tion until the end of the biliopancreatic duct. 
The blockade was maintained by necrotic 
material of the biliopancreatic duct wall, in-
creased by condensed secretion and cell infil-
tration. In the liver bile duct hyperplasia and 
necrosis were present. 28 days after com-
bined treatment of Na-selenite and DBTC, 
no signs of morphological changes in pan-
creas and liver were observed (data not 
shown). 
 
Distribution of tin and selenium in rats 
To further characterize the distribution 
pattern DBTC in the bodies of rats, concen-
tration of tin was determined in bile, liver and 
pancreas. These evaluation further provide 
data concerning the elimination of DBTC 
alone or in presence of Na-selenite. In the 
DBTC-group, the highest tin concentrations 
were measured in the collected bile and in 
the organs (liver and pancreas) 4 hours after 
administration of DBTC (Table 1). 7 days af-
ter DBTC application the highest tin concen-
trations were detected in livers. This corre-
sponds with the toxic effect of DBTC in this 
organ. Na-selenite administration diminished 
the tin concentration in bile, pancreas and 
liver in DBTC-treated rats 4 hours after 
DBTC administration. 7 days after DBTC-
administration, Na-selenite increases the tin 
concentration in urine. After this period Na-
selenite had no effects on pharmacokinetic 
parameters of tin, regarding to distribution 
and elimination. In the Na-selenite-group no 
higher tin levels were observed. 
Selenium concentrations were found after 
4 hours almost equal in pancreas and liver as 
well as in urine and bile regardless of treat-
ment groups. However, after 7 days we found 
selenium accumulation in the Na-selenite-
group in pancreas and liver (Table 2). In the 
Na-selenite + DBTC-group the concentra-
tions in pancreas and liver were lower, prob-
ably indicating tin- selenite complexes, 
which increases the tin elimination and re-
duced the toxicity in the organs (Table 2). 
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Table 1: Concentrations of tin (µg g-1) in bile, urine, pancreas and liver 4 hours and 7 days after daily 
administration of Na-selenite (Na-se; 5 mg kg-1 b.w. p.o.), after single dose of DBTC (6 mg kg-1 b.w. 
i.v.) and after daily administration of Na-selenite (5 mg kg-1 b.w. p.o.) + DBTC (6 mg kg-1 b.w. i.v.). Data 
indicate mean values ± SD of n = 6 rats in each group, *P < 0.05 for comparison of DBTC vs. corre-
sponding Na-selenite + DBTC group. 
 
Tin concentration (µg g-1) 
4 hour 7 days 
Na-se DBTC Na-se + DBTC Na-se DBTC Na-se + DBTC
Bile 0.03 ± 0 17.9 ± 1 6.2 ± 0.5* 0.02 ± 0 0.02 ± 0 0.01 ± 0 
Urine  0.04 ± 0  0.6 ± 0      0.2 ± 0* 0.03 ± 0 0.06 ± 0 1.20 ± 0* 
Pancreas  0.30 ± 0  2.3 ± 0 1.7 ± 0.2* 0.12 ± 0 0.30 ± 0 0.10 ± 0 
Liver 0.30 ± 0 12.6 ± 2 9.2 ± 1.7 0.20 ± 0   1.20 ± 0.3   1.20 ± 0.4 
 
 
Table 2: Concentration of selenium (µg g-1) in bile, urine, pancreas and liver 4 hours and 7 days after 
daily administration of Na-selenite (5 mg kg-1 b.w. p.o.), after single dose of DBTC (6 mg kg-1 b.w. i.v.) 
and after daily administration of Na-selenite (5 mg kg-1 b.w. p.o.) + DBTC (6 mg kg-1 b.w. i.v.). Data 
indicate mean values ± SD of n = 6 rats in each group, *P < 0.05 for comparison of DBTC vs. 
corresponding Na-selenite + DBTC group. 
 
Selenium concentration (µg g-1) 
4 hour 7 days 
Na-se DBTC Na-se + DBTC Na-se DBTC Na-se + DBTC
Bile 9.26 ± 0.8 8.7 ± 0.8 8.2 ± 0.7 0.01 ± 0 0.05 ± 0 0.05 ± 0 
Urine  3.30 ± 0.4 3.1 ± 0.6 3.2 ± 0.4 0.09 ± 0 0.10 ± 0 0.09 ± 0 
Pancreas  0.61 ± 0.02 0.5 ± 0.3  0.7 ± 0.03   1.16 ± 0.2 0.32 ± 0.04 0.32 ± 0.03* 
Liver 8.44 ± 0.8 8.0 ± 0.2 8.2 ± 0.8 10.24 ± 0.6 0.53 ± 0.01 1.04 ± 0.03* 
 
 
Thus prophylactic administration of Na-
selenite diminished the DBTC-induced le-
sions of the biliopancreatic duct, pancreas 
and liver associated with Na-selenite-en-
hanced elimination of tin. 
Further experiments were carried out in 
order to monitor biochemical parameters to 
quantify pancreatitis, liver damage, choles-
tasis and oxidative stress.  
 
Inhibition of the DBTC-induced oxidative 
stress by Na-selenite 
In a first attempt to monitor the modu-
lation of the DBTC-induced toxicity by Na-
selenite, serum malondialdehyd as marker of 
oxidative stress was evaluated. The DBTC-
treated rates revealed increased serum con-
centrations of MDA after 1, 2 and 4 hours 
with highest levels after 1 hours that con-
stantly decreased within the 24 hours time 
frame (Figure 4). Na-selenite significantly 
inhibited the DBTC-induced MDA concen-
trations in serum at all time points meas-
ured. The MDA levels in the Na-selenite-
group remained virtually unaltered. 
 
Inhibition of DBTC-induced acute pancrea-
titis by Na-selenite 
As a next step, the lipase activity was 
measured as pathobiochemical parameter of 
pancreatitis. In agreement with our observed 
morphological changes indicating acute pan-
creatitis induced upon DBTC treatments, se-
rum levels of lipase appeared strongly ele-
vated in the DBTC-group following 1, 2 and 
7 days (Figure 5). Lipase in serum of the 
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DBTC + Na-selenite group was significantly 
lower compared to the DBTC-group. In serum 
from rats treated with Na-selenite alone mini-
mal lipase was detected, respectively.  
 
Inhibition of DBTC-induced cholestasis by 
Na-selenite 
The increase in alkaline phosphatase ac-
tivity (AP) and bilirubin concentration in 
serum between 2 and 28 days after treatment 
with DBTC clearly indicates induction of a 
cholestasis (Figure 6).  
Figure 4: Modulation of serum MDA concentra-
tions by DBTC and Na-selenite. MDA-concentra-
tion were measured in serum of rats 1, 2, 4 and 
24 hours after administration of Na-selenite, 
DBTC and Na-selenite + DBTC. Data indicate 
mean values SD of n = 6 rats in each group, *P 
< 0.05 for comparison of DBTC vs. corresponding 
Na-selenite + DBTC group. 
 
Figure 5: Modulation of serum lipase by DBTC 
and Na-selenite. Activity of lipase was quantified 
in serum of rats 1, 2 and 7 days after administra-
tion of Na-selenite, DBTC and Na-selenite + 
DBTC. Mean values SD, n = 6 in each group. 
Data indicate mean values SD of n = 6 rats in 
each group, *P < 0.05 for comparison of DBTC vs. 
corresponding Na-selenite + DBTC group. 
a) 
b) 
Figure 6: Modulation of serum alkaline phospha-
tase and bilirubin by DBTC and Na-selenite. Alka-
line phosphatase activity (a) and bilirubin concen-
trations (b) were determined in serum of rats 2, 7, 
14 and 28 days after administration of Na-sele-
nite, DBTC and Na-selenite + DBTC. Data indi-
cate mean values SD of n = 6 rats in each group, 
*P < 0.05 for comparison of DBTC vs. correspond-
ing Na-selenite + DBTC group. 
 
 
Na-selenite significantly reduced the AP 
activity (Figure 6a) and the concentration of 
bilirubin (Figure 6b) in serum 7 to 28 days 
after DBTC administration in comparison to 
the DBTC-group. The rats in the Na-selenite-
group showed no pathological levels of biliru-
bin and AP and their levels were comparable 
to the Na-selenite + DBTC-group. 
 
Reduction of DBTC-induced liver damage 
by Na-selenite 
DBTC significantly increased both trans-
aminases (Alanin-Aminotransferase [ALAT] 
and Aspartat-Aminotransferase [ASAT]) that 
were monitored in a time frame between 2 
and 28 days after administration. Again, in 
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the combination group (Na-selenite + 
DBTC) transaminases were significantly de-
creased as compared to the DBTC-treated rats 
at all time points monitored in (Figure 7). 
 
Figure 7: Modulation of serum transaminases by 
DBTC and Na-selenite. Transaminases (Alanin- 
Aminotransferase [ALAT] and Aspartat-Amino-
transferase [ASAT]) were quantified in serum of 
rats 2, 7, 14 and 28 days after administration of 
Na-selenite, DBTC and Na-selenite + DBTC. Data 
indicate mean values ± SD of n = 6 rats in each 
group, *P < 0.05 for comparison of DBTC vs. cor-
responding Na-selenite + DBTC group. 
 
 
DISCUSSION 
In former studies we described the dimi-
nution by combined intravenous and oral se-
lenium treatment on bile duct-, pancreas-, 
liver- and thymus lesions in rats after DBTC 
application (Lemke et al., 2006). These re-
sults favoured the decreasing effects of sele-
nium on oxidative stress, monitored by 
MDA levels, as an important mechanism in 
scope of DBTC-induced pancreatitis. 
The significant decrease of MDA in se-
rum 2, 4, and 24 hours after DBTC admin-
istration caused by selenium suggests a 
mechanism that confers reduction of oxida-
tive stress in acute DBTC-induced pancre-
atitis. Oxygen radicals have been imple-
mented in the pathogenesis of acute pancre-
atitis (Schoenberg et al., 1992; Schulz et al., 
1999). In previous studies we found an im-
balance between oxidants and antioxidants in 
pancreas in the scope of DBTC-induced pan-
creatitis (Weber et al., 1995). The early mor-
phological changes observed in DBTC-pan-
creatitis may be a consequence of lipid perox-
idation. 
The prophylactic treatment with Na-sele-
nite significantly diminished the MDA con-
centration in serum following 2, 4 and 24 
hours after DBTC application and had an ef-
fect on the lipid peroxidation. In comparison 
to our former study, where Na-selenite was 
administered after induction of DBTC-pan-
creatitis, prophylactic administrations of Na-
selenite elicited a faster and more efficient 
impact on oxidative stress, characterized by 
significantly decreased MDA- levels in se-
rum. Application of Na-selenite in the ab-
sence of DBTC had no pathomorphological 
effects on bile duct, pancreas, liver and thy-
mus and did not increase serum parameters 
like amylase, lipase, bilirubin, transaminases 
and MDA. Lower selenium levels were pos-
tulated to occur in inflammatory reactions 
(Kuklinski et al., 1991, 1995; Kraft et al., 
1995; Wollschläger et al., 1999; Gärtner et 
al., 1997; McCloy, 1998; Scolapio et al., 
2004). Therefore the activity of the sele-
nium-dependent glutathione peroxidase, an 
important enzyme of endogenous antioxidant 
defence, is diminished (Neve et al., 1985; 
Saint-Georges et al., 1989; Zimmermann et 
al., 2000). Prophylactic application of Na-
selenite prior to an inflammatory reaction such 
as pancreatitis may increase the activity of the 
selenium-dependent glutathione-peroxidase 
in serum. This hypothesis is supported by 
the results of our measurements of selenium 
in serum before and after application of Na-
selenite and induction of a DBTC-pancreati-
tis. Increase of selenium levels following ap-
plication of Na- selenite may lead to a higher 
expression of glutathione-peroxidase and thus 
to an enhanced enzymatic antioxidant de-
fence in scope of DBTC-induced pancreati-
tis. The enhanced enzymatic antioxidant de-
fence could be one of the key factors respon-
sible for the minimal pancreas and liver dam-
ages after selenium treatment. 
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A further explanation for the observed 
lower toxicity of DBTC after selenium ad-
ministration could be the decrease of organ-
otin compounds in the bile caused by en-
hanced generation of water soluble adducts 
with selenium and a higher and delayed excre-
tion by the kidney (Table 2), as has been re-
ported before (Lemke et al., 2006). Moreo-
ver, it cannot be excluded that selenium 
forms unknown complexes with DBTC, 
which are not measurable by atomic absorp-
tion spectrometry. 
In vivo experiments revealed selenium 
to react with mercury and form albumin-
mercury- selenite complexes, thereby con-
ferring enhanced mercury elimination, re-
duction of pathohistological changes in or-
gans and mercury-induced lethality (Schrau-
zer, 1990, 1998; Wu et al., 1990). A similar 
mechanism of action appears feasible in 
terms of the presented decrease of DBTC-
induced toxicity by selenium. Accordingly, 
we did not find higher tin concentrations in 
urine after Na-selenite + DBTC administra-
tion after 4 hours and 4 days but after 7 days 
in comparison with the DBTC-group (Table 
1) suggesting a delayed enhancement of or-
ganotin elimination by selenium. 
After DBTC administration, high con-
centrations of organotin (10-5-10-6 M) are ex-
creted into the bile and induce cytotoxic ef-
fects on the biliopancreatic duct epithelium 
(Merkord et al., 1982). Partial necrosis of 
the surface epithelium of the biliopancreatic 
duct after administration of DBTC leads to 
the formation of plugs and concrements. 
The consequence of these biliopancreatic 
duct injuries is obstruction of the duct, choles-
tasis, pancreatic reflux, pancreatitis and liver 
lesions (Merkord et al., 2003). 
In our studies the biliary excretion of tin 
was reduced 4 hours after DBTC treatment 
in the Na-selenite + DBTC-group compared 
to the DBTC-group (Table 1). The urinary 
excretion was increased 7 days after DBTC 
treatment in the Na-selenite + DBTC-group 
compared to the DBTC-group (Table 1). Thus 
the formation of tin-selenite complexes ap-
pears likely. 
In other studies, we analyzed the local 
cytokine profile and infiltrating lymphocytes 
in this DBTC-rat model of pancreatitis. IL-
1ß, IL-6, IL-5 and IL-10 were immediately up 
regulated in the acute phase of disease, while 
lymphocyte-restricted expression of IL-2, IL-
2R and IFN-y was only found in the chronic 
course (Sparmann et al., 2001). Studies con-
cerning the effect of Na-selenite on these in-
flammatory parameters are under further in-
vestigation. 
The present study shows that a prophy-
lactic selenium treatment reduces the acute 
DBTC- induced pancreatitis and the toxicity 
of DBTC on biliopancreatic duct and liver. 
The data presented here point to a decrease 
of lipid peroxidation, characterized by low-
ered MDA levels in scope of DBTC-induced 
pancreatitis, following prophylactic applica-
tion of selenium. 
These results are confirmed by clinical 
studies, indicating a better outcome of pa-
tients with acute pancreatitis after a treat-
ment with selenium (Kuklinski et al., 1991, 
1995; Wollschläger et al., 1999). It is pos-
sible that a prophylactic substitution with 
Na- selenite has a strong beneficial effect on 
the clinical outcome in patients with ERCP. 
However, there are also conflicting results. As 
such, other clinical investigations described 
no effects of selenium in the therapy of an 
acute pancreatitis (Birk et al., 1995; Lindner 
et al., 2004; Steiner, 2011a, b). In account 
of these studies more experimental and 
clinical examinations are needed. 
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